2012-09-17 07:20:27 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Inflammatory Skin Diseases - Pipeline Review, H2 2012', provides an overview of the Inflammatory Skin Diseases therapeutic pipeline. This report provides information on the therapeutic development for Inflammatory Skin Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Inflammatory Skin Diseases. 'Inflammatory Skin Diseases - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463795_inflammatory_skin_diseases_pipeline_r ..


Note*: Certain sections in the report

may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Inflammatory Skin Diseases.
* A review of the Inflammatory Skin Diseases products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Inflammatory Skin Diseases pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Inflammatory Skin Diseases.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Inflammatory Skin Diseases pipeline depth and focus of Inflammatory Skin Diseases therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Inflammatory Skin Diseases Therapeutic Products under Development, Key Players in Inflammatory Skin Diseases Therapeutics, Inflammatory Skin Diseases Pipeline Overview, Inflammatory Skin Diseases Pipeline, Inflammatory Skin Diseases Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Inflammatory Skin Diseases Overview
Therapeutics Development
An Overview of Pipeline Products for Inflammatory Skin Diseases
Inflammatory Skin Diseases Therapeutics under Development by Companies
Inflammatory Skin Diseases Therapeutics under Investigation by Universities/Institutes
Mid Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Inflammatory Skin Diseases Therapeutics - Products under Development by Companies
Inflammatory Skin Diseases Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Inflammatory Skin Diseases Therapeutics Development
Biofrontera AG
Warner Chilcott Limited
CREABILIS Therapeutics S.r.l.
APEIRON Biologics AG
Inflammatory Skin Diseases - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
BF-PC/21 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BF-PC/18 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BF-PC/13 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CT327 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FLAPi - Drug Profile
Product Description
Mechanism of Action
R&D Progress
WC3027 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
StrataGraft Skin Tissue - Drug Profile
Product Description
Mechanism of Action
R&D Progress
APN201 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Inflammatory Skin Diseases Therapeutics - Drug Profile Updates
Inflammatory Skin Diseases Therapeutics - Dormant Products
Inflammatory Skin Diseases - Product Development Milestones
Featured News & Press Releases
Jul 14, 2010: Perrigo Company Confirms Patent Challenge For Clobetasol Propionate Emulsion Foam
Mar 20, 2008: Perrigo company announces launch of clobetasol propionate foam
Mar 11, 2008: Perrigo company receives final approval on Clobetasol Propionate foam

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463795&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.